Redhill Biopharma Ltd
NASDAQ:RDHL
Redhill Biopharma Ltd
Operating Expenses
Redhill Biopharma Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
Operating Expenses
$9.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Operating Expenses
-$4.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Operating Expenses
-$271.3m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Operating Expenses
-₪74.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-24%
|
Mediwound Ltd
NASDAQ:MDWD
|
Operating Expenses
-$19.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Operating Expenses
-₪77.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
0%
|
See Also
What is Redhill Biopharma Ltd's Operating Expenses?
Operating Expenses
9.6m
USD
Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Operating Expenses amounts to 9.6m USD.